Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 23 | Lane Kenneth ToddDirector, President & CEO | Tax withholding | F | $516K 19.7K sh | Mar 20, 2026 |
| 23 | Moore MichaelPresident | Open-market sale | SELL | $570K 65.0K sh | Mar 20, 2026 traded Mar 20, 2026 |
| 23 | Middleton Piers DayerEVP & Chief Operating Officer | Grant or award | A | $500K 6,643 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 22 | Bernstein HaroldPresident, R&D & CMO | Open-market sale · 10b5-1 plan | SELL | $297K 6,161 sh | Mar 20, 2026 traded Mar 20, 2026 |
| 21 | Hill Donna K.VP, Human Resources | Grant or award | A | — 39.2K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 21 | Neagle MatthewChief Operating Officer | Grant or award | A | — 826.5K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 21 | de Figueiredo Joao MDirector | Grant or award | A | — 17 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 21 | Statham JamiSVP, General Counsel | Grant or award | A | — 80.6K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 21 | Lane Kenneth ToddDirector, President & CEO | Option exercise | M | — 50.0K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 21 | Lane Kenneth ToddDirector, President & CEO | Option exercise | M | — 50.0K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 21 | Terreri Donald JosephController, Chief Acct Officer | Grant or award | A | — 25.0K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 21 | Benvenuti Raynard D.Director | Grant or award | A | — 51.8K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 21 | Nixon D. GailSenior VP, Human Resources | Option exercise | M | — 123.5K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 20 | Xu ZhenyuChief Scientific Officer | Open-market sale · 10b5-1 plan | SELL | $2,907 608 sh | Mar 20, 2026 traded Mar 19, 2026 |
| 20 | Camblong JurgiDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $21K 4,486 sh | Mar 20, 2026 traded Mar 19, 2026 |
| 20 | Menu PhilippeChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $2,913 608 sh | Mar 20, 2026 traded Mar 19, 2026 |
| 20 | David J. TaylorRSelf | Purchase | BUY | $1,001 – $15K | Mar 20, 2026 traded Mar 12, 2026 |
| 20 | Toth PeterEVP, Chief Sustain & Dev Off | Open-market sale · 10b5-1 plan | SELL | $324K 3,000 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 20 | Valente ManuelaChief People Officer | Open-market sale · 10b5-1 plan | SELL | $1,818 380 sh | Mar 20, 2026 traded Mar 19, 2026 |
| 20 | Muken RossPresident | Open-market sale · 10b5-1 plan | SELL | $5,671 1,183 sh | Mar 20, 2026 traded Mar 19, 2026 |
| 20 | Cardoza GeorgeChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $3,705 774 sh | Mar 20, 2026 traded Mar 19, 2026 |
| 20 | Van Well DaanChief Legal Officer | Open-market sale · 10b5-1 plan | SELL | $3,274 684 sh | Mar 20, 2026 traded Mar 19, 2026 |
| 20 | Van Tuyl ChristopherChief Legal Officer | Open-market sale | SELL | $72K 2,877 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 20 | Siegel Ian H.Director, CHIEF EXECUTIVE OFFICER, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $88K 34.4K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 19 | Bernstein HaroldPresident, R&D & CMO | Open-market sale · 10b5-1 plan | SELL | $187K 3,795 sh | Mar 20, 2026 traded Mar 20, 2026 |
| 19 | Travers DavidPresident and interim CFO | Open-market sale · 10b5-1 plan | SELL | $60K 23.7K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 19 | Hudson Daniel A.EVP & GENERAL COUNSEL | Grant or award | A | $500K 6,643 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 19 | Hudson Daniel A.EVP & GENERAL COUNSEL | Grant or award | A | $603K 8,005 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 19 | Stewart John REVP - Chief Financial Officer | Grant or award | A | — 6,714 sh | Mar 20, 2026 traded Mar 17, 2026 |
| 19 | Etzler Todd A.Executive Vice President & GC | Grant or award | A | — 3,020 sh | Mar 20, 2026 traded Mar 17, 2026 |
| 18 | Housman JeffreySee Remarks | Option exercise | M | $1.11M 20.0K sh | Mar 20, 2026 traded Mar 20, 2026 |
| 18 | Pierozzi LisaDirector | Gift | G | — 38.4K sh | Mar 20, 2026 traded Mar 17, 2026 |
| 17 | McIntyre PamelaChief Accounting Officer | Grant or award | A | — 45.0K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 17 | Hogan Michael JamesChief Business Officer | Open-market sale · 10b5-1 plan | SELL | $78K 1,800 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 17 | Marcus Andrew T.See Remarks | Grant or award | A | — 3,784 sh | Mar 20, 2026 traded Mar 19, 2026 |
| 17 | Nixon D. GailSenior VP, Human Resources | Grant or award | A | — 53.7K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 17 | Tabak ShawnCHIEF FINANCIAL OFFICER | Option exercise | M | — 124.0K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 17 | Neagle MatthewChief Operating Officer | Option exercise | M | — 826.6K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 17 | Malik PankajChief Accounting Officer | Grant or award | A | — 40.3K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 17 | Barbeau Michelle MarieChief Revenue Officer | Grant or award | A | — 70.0K sh | Mar 20, 2026 traded Mar 18, 2026 |